MedPath

Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patients

Phase 3
Conditions
Acute respiratory distress syndrom.
J68.3
Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors
Registration Number
IRCT20211010052718N2
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
74
Inclusion Criteria

Patients of both sexes and over 18 years old
They needed more than 2 hours of aggressive mechanical ventilation
GCS above 9
No underlying pulmonary problems

Exclusion Criteria

Patients receiving therapeutic doses of heparin enoxaparin, warfarin or dabigatran during the study
Uncontrolled bleeding or a history of bleeding such as cerebral hemorrhage in the past year and patients who had an epidural catheter or were implanted within 2 hours of hospitalization.
Patients with heparin sensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath